SOTERA HEALTH COMPANY Stock-Based Compensation
SOTERA HEALTH COMPANY (SHC) reported Stock-Based Compensation of $21.61 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-06
- SOTERA HEALTH COMPANY share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $7.22M, a 11.10% decline year-over-year.
- SOTERA HEALTH COMPANY share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $14.39M, a 98.74% increase year-over-year.
- SOTERA HEALTH COMPANY share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $7.57M, a 7.07% decline year-over-year.
- SOTERA HEALTH COMPANY share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $7.95M, a 18.80% decline year-over-year.
- SOTERA HEALTH COMPANY share-based payment arrangement, noncash expense for fiscal 2025 was $30.88M, a 16.04% decline from fiscal 2024.
- SOTERA HEALTH COMPANY share-based payment arrangement, noncash expense for fiscal 2024 was $36.78M, a 14.08% increase from fiscal 2023.
- SOTERA HEALTH COMPANY share-based payment arrangement, noncash expense for fiscal 2023 was $32.24M, a 51.99% increase from fiscal 2022.
- SOTERA HEALTH COMPANY share-based payment arrangement, noncash expense for fiscal 2022 was $21.21M, a 52.93% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $7.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $21.61M 10-Q · filed 2026-08-06 | $29.18M derived: sum of 3 quarters · filed 2026-08-06 | $37.13M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $14.39M 10-Q · filed 2026-05-05 | $21.96M derived: sum of 2 quarters · filed 2026-05-05 | $29.91M derived: sum of 3 quarters · filed 2026-05-05 | $38.03M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $7.57M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $15.52M derived: sum of 2 quarters · filed 2026-02-24 | $23.64M derived: sum of 3 quarters · filed 2026-08-06 | $30.88M 10-K · filed 2026-02-24 |
| 2025-09-30 | $7.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $16.07M derived: sum of 2 quarters · filed 2026-08-06 | $23.31M 10-Q · filed 2025-11-04 | $31.45M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $8.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $15.36M 10-Q · filed 2026-08-06 | $23.50M derived: sum of 3 quarters · filed 2026-08-06 | $33.29M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $7.24M 10-Q · filed 2026-05-05 | $15.39M derived: sum of 2 quarters · filed 2026-05-05 | $25.18M derived: sum of 3 quarters · filed 2026-05-05 | $35.36M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $8.14M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $17.93M derived: sum of 2 quarters · filed 2026-02-24 | $28.11M derived: sum of 3 quarters · filed 2026-02-24 | $36.78M 10-K · filed 2026-02-24 |
| 2024-09-30 | $9.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $19.97M derived: sum of 2 quarters · filed 2025-11-04 | $28.63M 10-Q · filed 2025-11-04 | $36.84M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $10.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $18.84M 10-Q · filed 2025-08-08 | $27.05M derived: sum of 3 quarters · filed 2026-02-24 | $35.42M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $8.66M 10-Q · filed 2025-05-01 | $16.87M derived: sum of 2 quarters · filed 2026-02-24 | $25.24M derived: sum of 3 quarters · filed 2026-02-24 | $33.61M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $8.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $16.58M derived: sum of 2 quarters · filed 2026-02-24 | $24.95M derived: sum of 3 quarters · filed 2026-02-24 | $32.24M 10-K · filed 2026-02-24 |
| 2023-09-30 | $8.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $16.75M derived: sum of 2 quarters · filed 2024-11-05 | $24.03M 10-Q · filed 2024-11-05 | $30.29M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $8.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $15.66M 10-Q · filed 2024-08-05 | $21.92M derived: sum of 3 quarters · filed 2025-02-27 | $26.53M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $7.29M 10-Q · filed 2024-05-02 | $13.54M derived: sum of 2 quarters · filed 2025-02-27 | $18.16M derived: sum of 3 quarters · filed 2025-02-27 | $23.96M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $6.26M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $10.87M derived: sum of 2 quarters · filed 2025-02-27 | $16.67M derived: sum of 3 quarters · filed 2025-02-27 | $21.21M 10-K · filed 2025-02-27 |
| 2022-09-30 | $4.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $10.42M derived: sum of 2 quarters · filed 2023-11-01 | $14.96M 10-Q · filed 2023-11-01 | $18.34M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $5.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $10.34M 10-Q · filed 2023-08-03 | $13.72M derived: sum of 3 quarters · filed 2024-02-27 | $17.27M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $4.54M 10-Q · filed 2023-05-03 | $7.92M derived: sum of 2 quarters · filed 2024-02-27 | $11.47M derived: sum of 3 quarters · filed 2024-02-27 | $14.96M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $3.38M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $6.93M derived: sum of 2 quarters · filed 2024-02-27 | $10.42M derived: sum of 3 quarters · filed 2024-02-27 | $13.87M 10-K · filed 2024-02-27 |
| 2021-09-30 | $3.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $7.04M derived: sum of 2 quarters · filed 2022-11-02 | $10.49M 10-Q · filed 2022-11-02 | $17.46M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $3.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $6.94M 10-Q · filed 2022-08-04 | $13.91M derived: sum of 3 quarters · filed 2023-02-28 | $14.81M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $3.45M 10-Q · filed 2022-05-05 | $10.42M derived: sum of 2 quarters · filed 2023-02-28 | $11.32M derived: sum of 3 quarters · filed 2023-02-28 | $12.71M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $6.97M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $7.87M derived: sum of 2 quarters · filed 2023-02-28 | $9.26M derived: sum of 3 quarters · filed 2023-02-28 | $10.99M 10-K · filed 2023-02-28 |
| 2020-09-30 | $901.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $2.29M derived: sum of 2 quarters · filed 2021-11-10 | $4.02M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $1.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $3.12M 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | $1.73M 10-Q · filed 2021-05-13 | |||
| 2019-12-31 | $6.88M 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |